A2A adenosine receptor protects tumors from antitumor T cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 35, 2006, Pages 13132-13137

  Ohta, Akio ^a,b   Gorelik, Elieser ^c   Prasad, Simon J ^d   Ronchese, Franca ^d   Lukashev, Dmitriy ^a,b   Wong, Michael K K ^c,e   Huang, Xiaojun ^c   Caldwell, Sheila ^f   Liu, Kebin ^f,g   Smith, Patrick ^a   Chen, Jiang Fan ^h   Jackson, Edwin K ^c   Apasov, Sergey ^a   Abrams, Scott ^f   Sitkovsky, Michail ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Cancer; Hypoxia; Inflammation; Therapy

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; CYCLIC AMP; CYTOKINE; GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; GROWTH INHIBITION; IMMUNE RESPONSE; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

ADENOSINE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTATION; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; TISSUE THERAPY;

EID: 33748357735     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0605251103     Document Type: Article

References (46)

1. Hellstrom, I., Hellstrom, K. E. & Pierce, G. E. (1968) Int. J. Cancer 3, 467-482.
2. Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H, Schreiber, R. D. & Allen, P. M. (2000) Immunity 13, 265-276.
3. Rosenberg, S. A. (2001) J. Intern. Med. 250, 462-475.
4. Pardoll, D. & Allison, J. (2004) Nat. Med. 887-92.
5. Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J. & Schreiber, R. D. (2001) Nature 410, 1107-1111.
6. Rapoport, A. P., Stadtmauer, E. A., Aqui, N., Badros, A., Cotte, J., Chrisley, L., Veloso, E., Zheng, Z., Westphal, S., Mair, R., et al. (2005) Nat. Med. 11, 1230-1237.
7. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) Science 274, 1363-1366.
8. Qin, Z. & Blankenstein, T. (2000) Immunity 12, 677-686.
9. Zinkernagel, R. M. (2001) Int. J. Cancer 93, 1-5.
10. Sutmuller, R. P., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N., Wildenberg, M. E., Allison, J. P., Toes, R. E., Offringa, R. & Melief, C. J. (2001) J. Exp. Med. 194, 823-832.
11. Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) Science 298, 850-854.
12. Pardoll, D. (2002) Proc. Natl. Acad. Sci. USA 99, 15840-15842.
13. Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C. C., Carroll, M. W., Moss, B., Rosenberg, S. A. & Restifo, N. P. (1999) Proc. Natl. Acad. Sci. USA 96, 2982-2987.
14. Phan,G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) Proc. Natl. Acad. Sci. USA 100, 8372-8377.
15. Takayama, H., Trenn, G. & Sitkovsky, M. V. (1988) J. Biol. Chem. 263, 2330-2336.
16. Huang, S., Koshiba, M., Apasov, S. & Sitkovsky, M. (1997) Blood 90, 1600-1610.
17. Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A. & Thiel, M. (2004) Annu. Rev. Immunol. 22, 657-682.
18. Ohta, A. & Sitkovsky, M. (2001) Nature 414, 916-920.
19. Harris, A. L. (2002) Nat. Rev. Cancer 2, 38-47.
20. Giatromanolaki, A., Sivridis, E., Kouskoukis, C., Gatter, K. C., Harris, A. L. & Koukourakis, M. I. (2003) Melanoma Res. 13, 493-501.
21. Decking, U. K., Schlieper, G., Kroll, K. & Schrader, J. (1997) Circ. Res. 81, 154-164.
22. Torgersen, K. M., Vang, T., Abrahamsen, H., Yaqub, S. & Tasken, K. (2002) Cell. Signalling 14, 1-9.
23. Fredholm, B. B., Ijzerman, A. P., Jacobson, K. A., Klotz, K.-N. & Linden, J. (2001) Pharmacol. Rev. 53, 527-552.
24. Koshiba, M., Kojima, H., Huang, S., Apasov, S. & Sitkovsky, M. V. (1997) J. Biol. Chem. 272, 25881-25889.
25. Armstrong, J. M., Chen, J. F., Schwarzschild, M. A., Apasov, S., Smith, P. T., Caldwell, C., Chen, P., Figler, H., Sullivan, G., Fink, S., et al. (2001) Biochem. J. 354, 123-130.
26. Apasov, S. G., Chen, J. F., Smith, P. T., Schwarzschild, M. A., Fink. J. S. & Sitkovsky, M. V. (2000) Br. J. Pharmacol. 131, 43-50.
27. Blay, J., White, T. D. & Hoskin, D. W. (1997) Cancer Res. 57, 2602-2605.
28. Hoskin, D. W., Butler, J. J., Drapeau, D., Haeryfar, S. M. & Blay, J. (2002) Int. J. Cancer 99, 386-395.
29. Jackson, E. K. & Dubey, R. K. (2001) Am. J. Physiol. 281, F597-F612.
30. Itoh, T., Storkus, W. J., Gorelik, E. & Lotze, M. T. (1994) J. Immunol. 153, 1202-1215.
31. Huang, X., Wong, M. K., Yi, H., Watkins, S., Laird, A. D, Wolf, S. F. & Gorelik, E. (2002) Cancer Res. 62, 5727-5735.
32. van Hall, T., van Bergen, J., van Veelen, P. A., Kraakman, M., Heukamp, L. C., Koning, F., Melief, C. J., Ossendorp, F. & Offringa, R. (2000) J. Immunol. 165, 869-877.
33. Linden, J. (2001) Annu. Rev. Pharmacol. Toxicol. 41, 775-787.
34. Ji, X.-D. & Jacobson, K. A. (1999) Drug Des. Discovery 16, 217-226.
35. Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A. & Zvartau, E. E. (1999) Pharmacol. Rev. 51, 83-133.
36. Pircher, H., Burki, K., Lang, R., Hengartner, H. & Zinkernagel, R. M. (1989) Nature 342, 559-561.
37. Prevost-Blondel, A., Zimmermann, C., Stemmer, C., Kulmburg, P., Rosenthal, F. M. & Pircher, H. (1998) J. Immunol. 161, 2187-2194.
38. Ryan, M. H., Bristol, J. A., McDuffie, E. & Abrams, S. I. (2001) J. Immunol. 167, 4286-4292.
39. Kemp, R. A. & Ronchese, F. (2001) J. Immunol. 167, 6497-6502.
40. Fredholm, B. B. (1995) Pharmacol. Toxicol. 76, 93-101.
41. Tanaka, K., Gorelik, E., Watanabe, M., Hozumi, N. & Jay, G. (1988) Mol. Cell. Biol. 8, 1857-1861.
42. Pacheco, R., Martinez-Navio, J. M., Lejeune, M., Climent, N., Oliva, H., Gatell, J. M., Gallart, T., Mallol, J., Lluis, C. & Franco, R. (2005) Proc. Natl. Acad. Sci. USA 102, 9583-9588.
43. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M. & Hengartner, H. (1994) Nature 369, 31-37.
44. Sitkovsky, M. V. (2003) Biochem. Pharmacol. 65, 493-501.
45. Folkman, J. (2003) Semin. Cancer Biol. 13, 159-167.
46. Jacobson, K. A., von Lubitz, D. K., Daly, J. W. & Fredholm, B. B. (1996) Trends Pharmacol. Sci. 17, 108-113.